More on IMUX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-623.1% Growth)
- Ratings (9.4 Score)
- Holders

Upcoming Events

- Earnings (10/29/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Immunic Inc. (NQ:IMUX)
Delayed: 7.41 +0.19 (2.63%)
Prev. Close $7.22  
Open$7.41 
52 Wk High$ 
52 Wk Low$ 
Day High$7.44 
Day Low$7.00 
P/E N/A  
EPS$ 
Volume367,154 

Friends, Peers and Foes (?): AUTL (more...)

Oct 23, 2026 06:08 AM Cantor Fitzgerald Starts Immunic Inc. (IMUX) at Overweight
Oct 21, 2026 07:01 AM Immunic presents MS drug data at Toronto neurology conference
Oct 21, 2026 07:00 AM Immunic Presents New Clinical, Biomarker, and Preclinical Data for Vidofludimus Calcium in Four Poster Presentations at MSToronto2026 - the 10th Joint ACTRIMS-ECTRIMS Meeting
Oct 19, 2026 06:30 AM Immunic Appoints Jaa Roberson as Chief People Officer
Oct 7, 2026 08:00 AM Immunic to present MS drug data at Toronto conference
Oct 7, 2026 08:00 AM Immunic to Present New Clinical, Biomarker and Preclinical Data on Vidofludimus Calcium at MSToronto2026 - the 10th Joint ACTRIMS-ECTRIMS Meeting
Oct 1, 2026 04:06 PM Form S-8 IMMUNIC, INC.
Sep 18, 2026 09:00 PM Form 4 IMMUNIC, INC. For: Sep 16 Filed by: Nagel Robert Thorvald
Sep 18, 2026 07:46 PM Form 4 IMMUNIC, INC. For: Sep 16 Filed by: BIOTECHNOLOGY VALUE FUND L P
Sep 11, 2026 05:25 PM Form 8-K IMMUNIC, INC. For: Sep 10
View All Articles

Entities mentioned with IMUX

View All Entities